Peter Thompson
Co-founder of Silverback Therapeutics, Cleave Therapeutics, and Edgewise Therapeutics
Contact
- Social accounts: linkedin
Companies
Company
Roles
Silverback Therapeutics
Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways.
CEO
Board Member
LucidLink
LucidLink is a San Francisco-based company founded in 2016 by Peter Thompson.
CEO
Cleave Biosciences, Inc.
Cleave Biosciences, Inc. is a company founded in 2011.
Board Member
Alpine Immune Sciences
Alpine Immune Sciences is a clinical-stage immunotherapy company developing treatments for cancer, autoimmune and inflammatory diseases.
Board Member
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a company founded in 2014.
Board Member
Edgewise Therapeutics
Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle.
Board Member
Janux Therapeutics
Janux Therapeutics is an immunotherapies for Cancer.
Board Member